DRTS
Price
$7.63
Change
+$0.13 (+1.73%)
Updated
Jan 15, 11:23 AM (EDT)
Capitalization
639.48M
49 days until earnings call
Intraday BUY SELL Signals
TECH
Price
$69.71
Change
+$1.31 (+1.92%)
Updated
Jan 15, 12:13 PM (EDT)
Capitalization
10.66B
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DRTS vs TECH

Header iconDRTS vs TECH Comparison
Open Charts DRTS vs TECHBanner chart's image
Alpha Tau Medical
Price$7.63
Change+$0.13 (+1.73%)
Volume$200
Capitalization639.48M
Bio-Techne
Price$69.71
Change+$1.31 (+1.92%)
Volume$890
Capitalization10.66B
DRTS vs TECH Comparison Chart in %
DRTS
Daily Signal:
Gain/Loss:
TECH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DRTS vs. TECH commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTS is a Hold and TECH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (DRTS: $7.50 vs. TECH: $68.40)
Brand notoriety: DRTS and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRTS: 416% vs. TECH: 151%
Market capitalization -- DRTS: $639.48M vs. TECH: $10.66B
DRTS [@Biotechnology] is valued at $639.48M. TECH’s [@Biotechnology] market capitalization is $10.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRTS’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 1 green FA rating(s).

  • DRTS’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 1 green, 4 red.
According to our system of comparison, both DRTS and TECH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRTS’s TA Score shows that 6 TA indicator(s) are bullish while TECH’s TA Score has 5 bullish TA indicator(s).

  • DRTS’s TA Score: 6 bullish, 4 bearish.
  • TECH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DRTS is a better buy in the short-term than TECH.

Price Growth

DRTS (@Biotechnology) experienced а +27.12% price change this week, while TECH (@Biotechnology) price change was +5.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

DRTS is expected to report earnings on Mar 05, 2026.

TECH is expected to report earnings on Feb 03, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($10.7B) has a higher market cap than DRTS($639M). DRTS YTD gains are higher at: 51.515 vs. TECH (16.307). TECH has higher annual earnings (EBITDA): 222M vs. DRTS (-35.36M). TECH has more cash in the bank: 145M vs. DRTS (72.2M). DRTS has less debt than TECH: DRTS (13.5M) vs TECH (394M). TECH has higher revenues than DRTS: TECH (1.22B) vs DRTS (0).
DRTSTECHDRTS / TECH
Capitalization639M10.7B6%
EBITDA-35.36M222M-16%
Gain YTD51.51516.307316%
P/E RatioN/A139.63-
Revenue01.22B-
Total Cash72.2M145M50%
Total Debt13.5M394M3%
FUNDAMENTALS RATINGS
TECH: Fundamental Ratings
TECH
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRTSTECH
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 14 days ago
71%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
DRTS
Daily Signal:
Gain/Loss:
TECH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMKX13.060.03
+0.23%
BNY Mellon Emerging Markets M
CCSGX25.460.01
+0.04%
Conestoga SMid Cap Institutional
FDSVX71.04N/A
N/A
Fidelity Growth Discovery
MACPX27.84-0.02
-0.07%
BlackRock Balanced Institutional
JSCGX28.95-0.05
-0.17%
Jacob Small Cap Growth Investor

DRTS and

Correlation & Price change

A.I.dvisor tells us that DRTS and ORMP have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRTS and ORMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
+14.33%
ORMP - DRTS
26%
Poorly correlated
+7.37%
IBRX - DRTS
24%
Poorly correlated
+7.09%
COGT - DRTS
24%
Poorly correlated
+7.11%
KRYS - DRTS
23%
Poorly correlated
-0.05%
TECH - DRTS
22%
Poorly correlated
+3.07%
More

TECH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with AXON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
+3.07%
AXON - TECH
61%
Loosely correlated
-1.92%
BMRN - TECH
55%
Loosely correlated
+1.59%
MRVI - TECH
48%
Loosely correlated
-1.99%
ARRY - TECH
44%
Loosely correlated
-6.70%
MRNA - TECH
44%
Loosely correlated
+2.47%
More